• bitcoinBitcoin(BTC)$80,402.00-0.17%
  • Midas Fasanara Global EuroMidas Fasanara Global Euro(MGLOEURO)$111,813.00-0.36%
  • ethereumEthereum(ETH)$2,329.74-0.77%
  • tetherTether(USDT)$1.000.00%
  • binancecoinBNB(BNB)$747.19-0.49%
  • rippleXRP(XRP)$1.31-0.64%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$100.950.05%
  • tronTRON(TRX)$0.3297150.67%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.03-0.15%
  • zcashZcash(ZEC)$1,265.79-3.05%
  • HyperliquidHyperliquid(HYPE)$80.05-0.45%
  • dogecoinDogecoin(DOGE)$0.0788220.82%
  • moneroMonero(XMR)$599.691.12%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$77.20-0.28%
  • chainlinkChainlink(LINK)$11.480.17%
  • leo-tokenLEO Token(LEO)$9.404.51%
  • cardanoCardano(ADA)$0.201138-2.06%
  • nearNEAR Protocol(NEAR)$4.57-0.55%
  • stellarStellar(XLM)$0.1697630.23%
  • bitcoin-cashBitcoin Cash(BCH)$287.14-1.15%
  • RainRain(RAIN)$0.006947-3.45%
  • litecoinLitecoin(LTC)$59.254.72%
  • Ethena USDeEthena USDe(USDE)$1.000.02%
  • daiDai(DAI)$1.000.00%
  • uniswapUniswap(UNI)$7.05-1.05%
  • CantonCanton(CC)$0.0997660.53%
  • avalanche-2Avalanche(AVAX)$8.840.06%
  • USD1USD1(USD1)$1.000.00%
  • suiSui(SUI)$0.92-0.06%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.230.74%
  • hedera-hashgraphHedera(HBAR)$0.074902-1.42%
  • tether-goldTether Gold(XAUT)$4,035.54-0.44%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • BittensorBittensor(TAO)$251.300.02%
  • shiba-inuShiba Inu(SHIB)$0.0000050.78%
  • quant-networkQuant(QNT)$194.00-2.61%
  • crypto-com-chainCronos(CRO)$0.0530540.55%
  • EthenaEthena(ENA)$0.195607-6.94%
  • BitwayBitway(BTW)$1.7417.02%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • MemeCoreMemeCore(M)$1.126.56%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.02%
  • okbOKB(OKB)$109.800.72%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • pepePepe(PEPE)$0.0000056.82%
  • aaveAave(AAVE)$131.41-0.55%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Cancer victims file class action against Johnson & Johnson over ‘fraudulent’ bankruptcies

May 24, 2024
in Business
Reading Time: 3 mins read
A A
Cancer victims file class action against Johnson & Johnson over ‘fraudulent’ bankruptcies
ShareShareShareShareShare

NEW YORK — A group of cancer victims sued Johnson & Johnson JNJ.N on Wednesday, accusing the healthcare company of committing fraud through repeated and continued efforts to use a shell company’s bankruptcy to resolve tens of thousands of lawsuits alleging its talc products contained asbestos and caused cancer.

YOU MAY ALSO LIKE

Apple slated to unveil first touchscreen laptops amid product blitz

New York Knicks, Rangers officially split into separate publicly traded companies

Five plaintiffs who seek to represent over 50,000 people who have sued J&J over its talc products filed the proposed class action in New Jersey federal court.

J&J has said that its baby powder and other talc products are safe, do not contain asbestos, and do not cause cancer. REUTERS

They allege that J&J’s bankruptcy strategy put billions of dollars out of the reach of plaintiffs in an attempt to “hinder, delay, and defraud these women and prevent them from ever having their day in court.”

“Johnson & Johnson is playing a dark game of chess with this country’s financial and judicial systems,” said Mike Papantonio, an attorney for the cancer plaintiffs.

J&J’s worldwide vice president of litigation, Erik Haas, said the lawsuit was a “Hail Mary pass” by plaintiffs’ lawyers who don’t want their clients to vote on the company’s latest proposed bankruptcy settlement.

“Why are they so desperate to stop the vote?” Haas said. “Our focus has been and will remain reaching a full, fair and final resolution of this litigation, and allowing the claimants to speak for themselves.”

Most of the talc lawsuits have been brought by women with ovarian cancer, while other cases involve people with mesothelioma, a deadly cancer linked to asbestos exposure.

J&J has said that its baby powder and other talc products are safe, do not contain asbestos, and do not cause cancer.

J&J was ordered to pay $45 million in a mesothelioma case while winning an ovarian cancer case. AFP via Getty Images

J&J first used a corporate maneuver called the “Texas two-step” to place its talc liabilities into a new subsidiary that then filed for bankruptcy in 2021.

The bankruptcy stopped the lawsuits from moving ahead against J&J, although it did not file for bankruptcy itself.

That and a second similar attempt to resolve the litigation failed as courts ruled that J&J and its subsidiary was not in financial distress so not eligible for bankruptcy.

The company said on May 1 that it plans to pursue a third bankruptcy once it gets enough votes to support a $6.48 billion talc settlement.

Wednesday’s lawsuit seeks a ruling that the Texas two-step transaction was fraudulent, because it was undertaken solely to shelter J&J’s assets from the talc litigation.

The suit takes aim at the legality of manipulating the financial status of J&J’s shell company. REUTERS

Subsequent transactions, including J&J’s spinoff of its consumer health business Kenvue, were also fraudulent, according to the lawsuit, which also seeks compensatory and punitive damages.

J&J says the planned third bankruptcy for its unit will be different because it will have support from over 75% of the people with talc-related claims.

The company has streamlined the proposed third bankruptcy by reaching separate settlements with law firms representing people with mesothelioma, as well as US states that alleged the company failed to warn consumers about the dangers of its talc products.

Litigation against J&J resumed after its second bankruptcy was dismissed. In recent trials, J&J was ordered to pay $45 million in a mesothelioma case while winning an ovarian cancer case.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Apple slated to unveil first touchscreen laptops amid product blitz
Business

Apple slated to unveil first touchscreen laptops amid product blitz

October 28, 2026
New York Knicks, Rangers officially split into separate publicly traded companies
Business

New York Knicks, Rangers officially split into separate publicly traded companies

October 27, 2026
The Orchard — Queens’ tallest building — is almost all leased out ahead of 2027 opening
Business

The Orchard — Queens’ tallest building — is almost all leased out ahead of 2027 opening

October 27, 2026
Ex-JPMorgan banker in ‘sex slave’ suit accused of getting sister to lie about kissing, racial remark: filing
Business

Ex-JPMorgan banker in ‘sex slave’ suit accused of getting sister to lie about kissing, racial remark: filing

October 27, 2026
Next Post
Man who survived 6 days trapped in truck after crash tells story

Man who survived 6 days trapped in truck after crash tells story

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Zelenskyy criticizes Trump, says energy truce is over

Zelenskyy criticizes Trump, says energy truce is over

October 25, 2026
Is The Stock Market Crashing? (What To Do Right Now)

Is The Stock Market Crashing? (What To Do Right Now)

October 22, 2026
Meta Doubles Down on AI Spending, Plans New Class C Shares

Meta Doubles Down on AI Spending, Plans New Class C Shares

October 25, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!